As cell therapies become increasingly diverse and pressure mounts to accelerate approvals, clinical testing programs face new and complex challenges.
But how are clinical testing programs adapting? And what could the future hold?
In our new report, five cell therapy experts describe how clinical testing programs are accommodating diverse therapeutic approaches, as well as anticipated changes in key testing areas, including:
- B-cell aplasia monitoring
- Cell enumeration and vector copy number measurement
- HLA typing
- Cytokine profiling
- Single-cell analysis
The cell therapy landscape is evolving fast. Discover what that means for clinical testing programs in this trends report from industry experts.
As a global CRO, we prioritize your study goals and clinical trial needs above all else. We aim to provide you with easy, accessible, and comprehensive technologies spanning a multitude of therapeutic areas.
Discover our range of services in immunology, proteomics, genomics, as well as related ML/AI and sample logistics services.
